» Articles » PMID: 30150990

Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8 T Cell Accumulation in the Omentum of Obesity-Associated Cancer Patients

Overview
Journal Front Immunol
Date 2018 Aug 29
PMID 30150990
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The omentum is enriched with pro-inflammatory effector memory CD8 T cells in patients with the obesity-associated malignancy, esophagogastric adenocarcinoma (EAC) and we have identified the chemokine macrophage inflammatory protein-1alpha as a key player in their active migration to this inflamed tissue. More recently, others have established that subsets of memory CD8 T cells can be classified based on their surface expression of CX3CR1; the specific receptor for the inflammatory chemokine fractalkine. CD8 T cells expressing intermediate levels (CX3CR1) are defined as peripheral memory, those expressing the highest levels (CX3CR1) are effector memory/terminally differentiated and those lacking CX3CR1 (CX3CR1) are classified as central memory. To date, the fractalkine:CX3CR1 axis has not been examined in the context of CD8 T cell enrichment in the omentum and here we examine this chemokines involvement in the accumulation of memory CD8 T cells in the omentum of EAC patients. Our data show that fractalkine is significantly enriched in the omentum of EAC patients and drives migration of T cells derived from EAC patient blood. Furthermore, CX3CR1 is endocytosed specifically by CD8 T cells upon encountering fractalkine, which is consistent with the significantly diminished frequencies of CX3CR1 and CX3CR1 CD8 T cells in the fractalkine-rich environment of omentum in EAC, relative to matched blood. Fractalkine-mediated endocytosis of CX3CR1 by CD8 T cells is sustained and is followed by enhanced surface expression of L-selectin (CD62L). These novel data align with our findings that circulating CX3CR1 CD8 T cells express higher levels of L-selectin than CX3CR1 CD8 T cells. This is consistent with previous reports and implicates fractalkine in the conversion of CX3CR1 CD8 T cells to a CX3CR1 phenotype characterized by alterations in the migratory capacity of these T cells. For the first time, these findings identify fractalkine as a driver of T cell migration to the omentum in EAC and indicate that CD8 T cells undergo sequenced fractalkine-mediated alterations in CX3CR1 and L-selectin expression. These data implicate fractalkine as more than a chemotactic cytokine in obesity-associated meta-inflammation and reveal a role for this chemokine in the maintenance of the CX3CR1 CD8 T cell populations.

Citing Articles

Adipose tissue from oesophageal adenocarcinoma patients is differentially affected by chemotherapy and chemoradiotherapy regimens altering immune cell phenotype and cancer cell metabolism.

OConnell F, Mylod E, Donlon N, Davern M, Butler C, OConnor N Transl Oncol. 2025; 53:102302.

PMID: 39965288 PMC: 11876773. DOI: 10.1016/j.tranon.2025.102302.


CX3CR1CD8 T cells: Key players in antitumor immunity.

Ma J, Wu Y, Wu S, Fang Z, Chen L, Jiang J Cancer Sci. 2024; 115(12):3838-3845.

PMID: 39377122 PMC: 11611776. DOI: 10.1111/cas.16359.


The multifactorial effect of obesity on the effectiveness and outcomes of cancer therapies.

Lysaght J, Conroy M Nat Rev Endocrinol. 2024; 20(12):701-714.

PMID: 39313571 DOI: 10.1038/s41574-024-01032-5.


Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma.

Davern M, O Donovan C, Donlon N, Mylod E, Gaughan C, Bhardwaj A Biomedicines. 2024; 12(4).

PMID: 38672174 PMC: 11048527. DOI: 10.3390/biomedicines12040819.


Real-time ex vivo monitoring of NK cell migration toward obesity-associated oesophageal adenocarcinoma following modulation of CX3CR1.

Mylod E, OConnell F, Donlon N, Davern M, Marion C, Butler C Sci Rep. 2024; 14(1):4017.

PMID: 38369570 PMC: 10874956. DOI: 10.1038/s41598-024-54390-5.


References
1.
Conroy M, Galvin K, Kavanagh M, Mongan A, Doyle S, Gilmartin N . CCR1 antagonism attenuates T cell trafficking to omentum and liver in obesity-associated cancer. Immunol Cell Biol. 2016; 94(6):531-7. DOI: 10.1038/icb.2016.26. View

2.
Alberti K, Zimmet P, Shaw J . Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006; 23(5):469-80. DOI: 10.1111/j.1464-5491.2006.01858.x. View

3.
Shah R, Hinkle C, Ferguson J, Mehta N, Li M, Qu L . Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes. 2011; 60(5):1512-8. PMC: 3292325. DOI: 10.2337/db10-0956. View

4.
Staniland A, Clark A, Wodarski R, Sasso O, Maione F, DAcquisto F . Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice. J Neurochem. 2010; 114(4):1143-57. DOI: 10.1111/j.1471-4159.2010.06837.x. View

5.
Dieli F, Poccia F, Lipp M, Sireci G, Caccamo N, Di Sano C . Differentiation of effector/memory Vdelta2 T cells and migratory routes in lymph nodes or inflammatory sites. J Exp Med. 2003; 198(3):391-7. PMC: 2194087. DOI: 10.1084/jem.20030235. View